Literature DB >> 26064289

Osteopontin can decrease the cartilage cellular inflammatory reaction induced by LPS.

Fengsheng Li1, Dongping Ye1, Jun Duan1, Hao Sun1.   

Abstract

OBJECTIVE: This study aims to explore the effect of osteopontin on the inflammatory reaction of cartilage cells stimulated by LPS and its possible signal pathway.
METHODS: The inflammatory reaction of cartilage cells was induced by LPS, and then the cells were treated with OPN and PD98059 respectively. The expression of TNF-α, IL-1β and ERK1/2 were detected by ELISA or Western-blotting methods.
RESULTS: Osteopontin could decrease the cartilage cellular inflammatory reaction induced by LPS with dose dependent, while PD98059 could reverse the inhibition of osteopontin.
CONCLUSION: Osteopontin could decrease the cartilage cellular inflammatory reaction induced by LPS, which may be associated with the ERK1/2 signal pathway.

Entities:  

Keywords:  ERK1/2 signal pathway; Osteopontin; inflammatory reaction

Year:  2015        PMID: 26064289      PMCID: PMC4443123     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

1.  Prevalence of disabilities and associated health conditions among adults--United States, 1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2001-02-23       Impact factor: 17.586

2.  Inflammation in osteoarthritis.

Authors:  Steven B Abramson
Journal:  J Rheumatol Suppl       Date:  2004-04

3.  Usefulness of specific OA biomarkers, thrombin-cleaved osteopontin, in the posterior cruciate ligament OA rabbit model.

Authors:  S G Gao; L Cheng; C Zeng; L C Wei; F J Zhang; J Tian; M Tu; W Luo; G H Lei
Journal:  Osteoarthritis Cartilage       Date:  2012-09-28       Impact factor: 6.576

4.  Synovial tissue inflammation in early and late osteoarthritis.

Authors:  M J Benito; D J Veale; O FitzGerald; W B van den Berg; B Bresnihan
Journal:  Ann Rheum Dis       Date:  2005-02-24       Impact factor: 19.103

5.  Osteopontin: an intrinsic inhibitor of inflammation in cartilage.

Authors:  M G Attur; M N Dave; S Stuchin; A J Kowalski; G Steiner; S B Abramson; D T Denhardt; A R Amin
Journal:  Arthritis Rheum       Date:  2001-03

6.  Comparison of cartilage histopathology assessment systems on human knee joints at all stages of osteoarthritis development.

Authors:  C Pauli; R Whiteside; F L Heras; D Nesic; J Koziol; S P Grogan; J Matyas; K P H Pritzker; D D D'Lima; M K Lotz
Journal:  Osteoarthritis Cartilage       Date:  2012-02-18       Impact factor: 6.576

Review 7.  Osteoarthritis, angiogenesis and inflammation.

Authors:  C S Bonnet; D A Walsh
Journal:  Rheumatology (Oxford)       Date:  2004-08-03       Impact factor: 7.580

8.  Accelerated development of aging-associated and instability-induced osteoarthritis in osteopontin-deficient mice.

Authors:  Yuichiro Matsui; Norimasa Iwasaki; Shigeyuki Kon; Daisuke Takahashi; Junko Morimoto; Yutaka Matsui; David T Denhardt; Susan Rittling; Akio Minami; Toshimitsu Uede
Journal:  Arthritis Rheum       Date:  2009-08

Review 9.  The potential utility of high-intensity ultrasound to treat osteoarthritis.

Authors:  H J Nieminen; A Salmi; P Karppinen; E Hæggström; S A Hacking
Journal:  Osteoarthritis Cartilage       Date:  2014-08-12       Impact factor: 6.576

10.  Osteopontin as two-sided mediator of intestinal inflammation.

Authors:  Katja Heilmann; Ute Hoffmann; Ellen Witte; Christoph Loddenkemper; Christian Sina; Stefan Schreiber; Claudia Hayford; Pamela Holzlöhner; Kerstin Wolk; Elianne Tchatchou; Verena Moos; Martin Zeitz; Robert Sabat; Ursula Günthert; Bianca Maria Wittig
Journal:  J Cell Mol Med       Date:  2008-07-04       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.